₹2,100 crore UK bet marks its boldest global leap yet, adding an NHS-backed, asset-light growth engine. But the real story lies in how this deal could reshape its long-term mix.”/>
A ₹2,100 cr leap: How could this UK acquisition rewrite Narayana’s growth story?
